CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC) (CARE+)
Human Immunodeficiency Virus
About this trial
This is an interventional supportive care trial for Human Immunodeficiency Virus focused on measuring Linkage to HIV care following release from prison, Anti-retroviral therapy adherence after release from prison, HIV loads after release from prison, information technology and ART adherence, information technology and linkage to HIV care
Eligibility Criteria
Inclusion Criteria:
- Currently detained in jail or released from the jail/prison 6 months ago or less
- 18 years of age or older
- English speaking
- Able to provide informed consent for research participation
- Anticipated release from the DOC to the community (or living in the community if recently released ex-detainee)
- Confirmed to be HIV-infected by self-report
- Live in metropolitan Washington, DC area
- Able to read at 8th grade level as assessed by brief literacy screen
Exclusion Criteria:
- Expected release to restricted setting (or currently living in a restricted setting if recruited in the community), including residential drug treatment, sober house, half-way house, or similar
Sites / Locations
- Family and Medical Counseling Services
Arms of the Study
Arm 1
Arm 2
Sham Comparator
Experimental
Control Arm
CARE tool and cell phone/text messaging
Participants in the Control Arm will receive standard discharge services according to the standards of care for that facility. In addition, participants in this arm will view an educational video on opiate overdose prevention. Study participants in the Control Arm will be followed after release/study enrollment, just like participants in the Intervention Arm, and Plasma Viral Loads will be collected from them at baseline and follow-up.
The Intervention Arm will complete the CARE tool device, a technology based HIV-counseling tool, and will receive text message reminders about HIV medical appointments and the importance of taking HIV medications. Study participants in this arm will be followed after release/study enrollment, just like participants in the Control Arm, and Plasma Viral Loads will be collected from them at baseline and follow-up.